APS is caused by different LMNA mutations that have in common an early and accelerated aging process and is also characterized by variable degrees of fat loss (partial or generalized lipodystrophy), metabolic alterations and comorbidities that affect skeleton, muscles and heart. This evidence concerns the gene LMNA and autoimmune polyendocrinopathy.